Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Precision medicine focuses on DNA abnormalities, but not all tumors have tractable genomic alterations. The WINTHER trial (NCT01856296) navigated patients to therapy on the basis of fresh biopsy-derived DNA sequencing (arm A; 236 gene panel) or RNA expression (arm B; comparing tumor to normal). The...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Nat Med
Asıl Yazarlar: Rodon, Jordi, Soria, Jean-Charles, Berger, Raanan, Miller, Wilson H., Rubin, Eitan, Kugel, Aleksandra, Tsimberidou, Apostolia, Saintigny, Pierre, Ackerstein, Aliza, Braña, Irene, Loriot, Yohann, Afshar, Mohammad, Miller, Vincent, Wunder, Fanny, Bresson, Catherine, Martini, Jean-François, Raynaud, Jacques, Mendelsohn, John, Batist, Gerald, Onn, Amir, Tabernero, Josep, Schilsky, Richard L., Lazar, Vladimir, Lee, J. Jack, Kurzrock, Razelle
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6599610/
https://ncbi.nlm.nih.gov/pubmed/31011205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-019-0424-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller